Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Strides Pharma Science Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (302)
Cancellation by sponsor (46)
Prescription medicine registration (2)

Date

2026 (24)
2025 (24)
2024 (16)
2022 (23)
2021 (10)
2020 (48)
2019 (1)
2018 (4)
2015 (9)
2013 (41)
2012 (57)
2011 (51)
2010 (17)
2009 (1)
2008 (12)
2006 (7)
2005 (2)
2004 (3)

Search

Sponsor content

350 result(s) found, displaying 241 to 250

MOCLOBERIX moclobemide 300 mg film-coated tablet blister pack (184083)

19 April 2012

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MOCLOBERIX moclobemide 300 mg film-coated tablet blister pack.
LEVETIRAM levetiracetam 1000mg film coated tablet blister pack (177069)

17 April 2012

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LEVETIRAM levetiracetam 1000mg film coated tablet blister pack.
LEVETIRAM levetiracetam 500mg film coated tablet blister pack (177052)

17 April 2012

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LEVETIRAM levetiracetam 500mg film coated tablet blister pack.
LEVACTAM levetiracetam 250mg film coated tablet blister pack (177053)

17 April 2012

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LEVACTAM levetiracetam 250mg film coated tablet blister pack.
LEVACTAM levetiracetam 1000mg film coated tablet blister pack (177055)

17 April 2012

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LEVACTAM levetiracetam 1000mg film coated tablet blister pack.
LEVACTAM levetiracetam 500mg film coated tablet blister pack (177056)

17 April 2012

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LEVACTAM levetiracetam 500mg film coated tablet blister pack.
LEVACTAM levetiracetam 750mg film coated tablet blister pack (177058)

17 April 2012

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LEVACTAM levetiracetam 750mg film coated tablet blister pack.
LEVETIRAM levetiracetam 250mg film coated tablet blister pack (177061)

17 April 2012

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LEVETIRAM levetiracetam 250mg film coated tablet blister pack.
LEVETIRAM levetiracetam 750mg film coated tablet blister pack (177067)

17 April 2012

ARTG

Australian Register of Therapeutic Goods (ARTG) information for LEVETIRAM levetiracetam 750mg film coated tablet blister pack.
GN-INDAPAMIDE indapamide hemihydrate 2.5mg sugar coated tablet blister pack (184254)

5 April 2012

ARTG

Australian Register of Therapeutic Goods (ARTG) information for GN-INDAPAMIDE indapamide hemihydrate 2.5mg sugar coated tablet blister pack.

Pages

First page
Previous page
…
Page 21
Page 22
Page 23
Page 24
Current page 25
Page 26
Page 27
Page 28
Page 29
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.